True and I'm worried that the build up occurred to early but I expect that was because cooper was expecting approval before Christmas hence the gap raise before NASDAQ listing. So your right, he's going to have to do a little magic to pull the strings together. However, on the plus side, 40% of revenue for the new trial was expected to be received in FY23. So that should help with cash burn. Lets hope there are a few more dominos to fall in place as well.
CDX Price at posting:
26.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
